Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Immunogenetics ; 69(1): 13-27, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27541597

ABSTRACT

Interleukin-7 is essential for the development and maintenance of T cells, and the expression of the IL-7 receptor is tightly regulated at every stage of the T cell's lifespan. In mature CD8 T cells, IL-7 plays important roles in cell survival, peripheral homeostasis, and cytolytic function. The IL-7 receptor alpha-chain (CD127) is expressed at high levels on naïve and memory cells, but it is rapidly downregulated upon IL-7 stimulation. In this study, we illustrate the dynamicity of the CD127 promoter and show that it possesses positive as well as negative regulatory sites involved in upregulating and downregulating CD127 expression, respectively. We cloned the CD127 gene promoter and identified key cis-regulatory elements required for CD127 expression in mature resting primary CD8 T cells. The core promoter necessary for efficient basal transcription is contained within the first 262 bp upstream of the TATA box. Additional positive regulatory elements are located between -1200 and -2406 bp, conferring a further 2- to 4-fold enhancement in gene expression. While transcription of the CD127 gene is increased directly through a glucocorticoid response element located between -2255 and -2269 bp upstream of the TATA box, we identified a suppressive region that lies upstream of 1760 bp from the TATA box, which is likely involved in the IL-7-mediated suppression of CD127 transcription. Finally, we illustrated IL-7 does not bias alternative splicing of CD127 transcripts in primary human CD8 T cells.


Subject(s)
Anti-Inflammatory Agents/pharmacology , CD8-Positive T-Lymphocytes/metabolism , Dexamethasone/pharmacology , Gene Expression Regulation/drug effects , Interleukin-7/metabolism , Receptors, Interleukin-7/genetics , Blotting, Western , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/drug effects , Cells, Cultured , Flow Cytometry , Humans , Promoter Regions, Genetic/genetics , Receptors, Interleukin-7/metabolism , Regulatory Sequences, Nucleic Acid/genetics , Signal Transduction/drug effects , Transcription, Genetic
2.
Cell Immunol ; 306-307: 41-52, 2016.
Article in English | MEDLINE | ID: mdl-27423467

ABSTRACT

Given the essential role interleukin (IL)-7 plays in T-cell survival, homeostasis and function, it is no surprise expression of the IL-7 receptor alpha-chain (CD127) is tightly regulated. We have previously shown IL-7 binding to its receptor on the surface of CD8 T cells leads to both suppression of CD127 gene transcription and loss of existing CD127 protein from the cell membrane. Indeed upon binding IL-7, CD127 is rapidly internalized into early endosomes where phosphorylation by JAK targets the receptor for degradation. We now show that IL-7 induces the expression of suppressor of cytokine signaling (SOCS) proteins CIS, SOCS1 and SOCS2 through the JAK/STAT-5 pathway and that CIS and SOCS2 specifically interact with CD127 in early endosomes and direct the receptor complex to the proteasome for degradation. These results illustrate how expression of the IL-7 receptor and thus IL-7 signaling is modulated in human CD8 T cells by a negative feedback mechanism dependent on members of the SOCS family of proteins.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Interleukin-7 Receptor alpha Subunit/metabolism , Interleukin-7/metabolism , Suppressor of Cytokine Signaling 1 Protein/metabolism , Suppressor of Cytokine Signaling Proteins/metabolism , Cells, Cultured , Endosomes/metabolism , Humans , Janus Kinases/metabolism , Proteasome Endopeptidase Complex/metabolism , Protein Binding , Proteolysis , STAT5 Transcription Factor/metabolism , Signal Transduction , Suppressor of Cytokine Signaling 1 Protein/genetics , Suppressor of Cytokine Signaling Proteins/genetics
3.
Immunol Cell Biol ; 94(2): 196-207, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26272555

ABSTRACT

Interleukin-7 (IL-7), a key immunoregulatory cytokine, plays an essential role in peripheral T-cell homeostasis and function. Signaling via the IL-7 receptor is tightly regulated and we and others have shown IL-7 provides negative feedback on its own signaling by downregulating expression of the IL-7 receptor alpha-chain (CD127) through both suppression of CD127 gene transcription and by internalization of existing CD127 proteins from the cell membrane. We show here for the first time in primary human CD8 T cells that upon stimulation with IL-7, CD127 is internalized through clathrin-coated pits, a process dependent on both lipid-raft formation and the activity of dynamin. As visualized by confocal microscopy, CD127 shows increased co-localization with clathrin within 5 min of IL-7 stimulation and within 15-30 min is seen in multiple intracellular punctae co-localizing with the early endosomal marker EEA1. By 2 h after addition of IL-7, CD127 staining associates with the late endosomal marker RAB7 and with the proteasomal 20S subunit. By inducing receptor internalization and translocation from early endosomes to the proteasome, IL-7 directly influences its receptor density on the cell surface and thus regulates the intensity of its own signaling cascades. Given the important role IL-7 plays in T-cell development, homeostasis and function, deciphering how expression of its receptor is controlled on the cell surface is essential in understanding how T-cell activity can be regulated in different microenvironments and in response to different pathogens.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Clathrin-Coated Vesicles/metabolism , Interleukin-7 Receptor alpha Subunit/metabolism , Interleukin-7/physiology , Membrane Microdomains/metabolism , Proteasome Endopeptidase Complex/metabolism , Cells, Cultured , Clathrin/metabolism , Endocytosis , Feedback, Physiological , Homeostasis , Humans , Microscopy, Confocal , Proteolysis , Signal Transduction
4.
PLoS One ; 9(7): e102677, 2014.
Article in English | MEDLINE | ID: mdl-25033393

ABSTRACT

Expression of the IL-7 receptor α-chain (CD127) is decreased on CD8 T-cells in HIV infected patients and partially recovers in those receiving antiretroviral therapy with sustained viral suppression. We have shown that soluble HIV Tat protein down regulates CD127 expression on CD8 T-cells isolated from healthy HIV-negative individuals. Tat is taken up by CD8 T-cells via endocytosis, exits the endosome and then translocates to the inner leaflet of the cell membrane where it binds to the cytoplasmic tail of CD127 inducing receptor internalization and degradation by the proteasome. This down regulation of CD127 by Tat results in impaired CD8 T-cell function. Interestingly, suppression of CD127 by Tat is reversible and requires the continual presence of Tat in the culture media. We thus questioned whether the low IL-7 receptor expression evident on CD8 T-cells in HIV+ patients was similarly reversible and if suppression of the receptor could be maintained ex vivo by Tat protein alone. We show here that when CD8 T-cells isolated from HIV+ patients are incubated alone in fresh medium, low CD127 expression on the cell surface recovers to normal levels. This recovery of CD127, however, is completely inhibited by the addition of HIV Tat protein to the culture media. This study then provides evidence that soluble factor(s) are responsible for low CD127 expression on circulating CD8 T-cells in HIV+ individuals and further implicates Tat in suppressing this receptor essential to CD8 T-cell proliferation and function.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , HIV Infections/immunology , Interleukin-7 Receptor alpha Subunit/biosynthesis , tat Gene Products, Human Immunodeficiency Virus/pharmacology , Adult , Anti-HIV Agents/therapeutic use , Antiretroviral Therapy, Highly Active , CD4-CD8 Ratio , Cell Proliferation , HIV Infections/drug therapy , Humans , Interleukin-7 Receptor alpha Subunit/immunology , Lymphocyte Activation/immunology , Male , Middle Aged , Signal Transduction/immunology , Young Adult , tat Gene Products, Human Immunodeficiency Virus/metabolism
5.
Immunol Cell Biol ; 91(2): 149-58, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23207282

ABSTRACT

Interleukin (IL)-7 is an essential nonredundant cytokine, and throughout the lifespan of a T-cell signaling via the IL-7 receptor influences cell survival, proliferation and differentiation. It is therefore no surprise that expression of the IL-7 receptor alpha-chain (CD127) is tightly regulated. We have previously shown that IL-7 downregulates expression of CD127 at the cell surface and now elucidate the kinetics of that suppression and demonstrate that IL-7 downregulates CD127 transcripts and surface protein in primary human CD8 T cells by two separate pathways. We show that IL-7 induces the initial reduction in cell-surface CD127 protein independent of transcriptional suppression, which is delayed by 40-60 min. Although IL-7-mediated downregulation of CD127 transcripts is dependent on Janus kinase (JAK)/STAT5, the early downregulation of surface CD127 protein is independent of JAK activity. The data further illustrate that low levels of IL-7 induce smaller and transient decreases in CD127 transcripts and surface protein, whereas higher concentrations induce more profound and sustained suppression. Such flexibility in receptor expression likely allows for fine-tuned immune responses in human CD8 T cells in different microenvironments and in response to different immunological challenges.


Subject(s)
CD8-Positive T-Lymphocytes/metabolism , Down-Regulation/drug effects , Interleukin-7/pharmacology , Receptors, Interleukin-7/genetics , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/enzymology , Cell Membrane/drug effects , Cell Membrane/metabolism , Dose-Response Relationship, Immunologic , Humans , Janus Kinases/metabolism , Jurkat Cells , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Interleukin-7/metabolism , STAT3 Transcription Factor/metabolism , STAT5 Transcription Factor/metabolism , Signal Transduction/drug effects , Signal Transduction/immunology , Time Factors , Transcription, Genetic/drug effects
6.
J Immunol ; 185(5): 2854-66, 2010 Sep 01.
Article in English | MEDLINE | ID: mdl-20660706

ABSTRACT

IL-7 signaling is essential to CD8 T cell development, activation, and homeostasis. We have previously shown decreased expression of the IL-7R alpha-chain (CD127) on CD8 T cells in HIV(+) patients and that this downregulation is mediated at least in part by the HIV Tat protein. We show in this study that CD127 has a prolonged t(1/2) in resting CD8 T cells and continuously recycles on and off the cell membrane. We also demonstrate soluble Tat protein significantly decreases the t(1/2) of CD127. Soluble Tat is taken up from the medium and accumulates in CD8 T cells with a peak of 6 h. Once inside the cell, Tat exits the endosomes during their normal acidification and enters the cytosol. Tat then translocates to the inner leaflet of the cell membrane, where it binds directly to the cytoplasmic tail of CD127, inducing receptor aggregation and internalization through a process dependent on microtubules. Tat appears to then target CD127 for degradation via the proteasome. By removing CD127 from the cell surface, the HIV Tat protein is thus able to reduce IL-7 signaling and impair CD8 T cell proliferation and function.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Cell Membrane/immunology , Cell Membrane/metabolism , Protein Subunits/metabolism , Receptors, Interleukin-7/metabolism , Resting Phase, Cell Cycle/immunology , tat Gene Products, Human Immunodeficiency Virus/physiology , CD8-Positive T-Lymphocytes/virology , Cell Membrane/virology , Cells, Cultured , Cycloheximide/pharmacology , Down-Regulation/immunology , Endocytosis , Endosomes/immunology , Endosomes/metabolism , Exocytosis/immunology , Humans , Hydrogen-Ion Concentration , Interleukin-7/antagonists & inhibitors , Interleukin-7/physiology , Protein Subunits/antagonists & inhibitors , Protein Subunits/biosynthesis , Protein Synthesis Inhibitors/pharmacology , Protein Transport/immunology , Receptors, Interleukin-7/antagonists & inhibitors , Receptors, Interleukin-7/biosynthesis , Signal Transduction/immunology , Solubility , tat Gene Products, Human Immunodeficiency Virus/metabolism
7.
Mol Cell Neurosci ; 41(1): 85-93, 2009 May.
Article in English | MEDLINE | ID: mdl-19233279

ABSTRACT

Microtubule associated proteins (MAP) have been shown to play a role in microtubule stability in axons and dendrites, in determining neuronal shape and in regulating the balance between rigidity and plasticity in neuronal processes. MAP1a is the most abundant MAP in the adult brain, localized in axons and dendrites of neurons. MAP1a associates with three light chain molecules (LC1, LC2, LC3) that have been shown to bind microtubules independent of heavy chain molecules. In the present study we investigate the role of MAP1a associated light chain molecules in stabilizing microtubules and altering microtubule dynamics in vivo. All three light chain molecules co-localized with microtubules by fluorescence microscopy and bound taxol stabilized microtubules in an in vitro binding assay. LC-microtubule binding was associated with increased microtubule stability as shown by co localization of LC molecules with detyrosinated microtubules and increased amounts of detyrosinated tubulin in whole cell extracts. Both LC1 and LC2 binding to microtubules reorganized microtubules into wavy bundles that were resistant to nocodazole induced drug depolymerization. In contrast, LC3 bound microtubules were not resistant to nocodazole and the microtubule network of LC3 expressing cells was similar to media controls. Although LC3 bound microtubules were not resistant to drug induced depolymerization, in vivo measurement of microtubule dynamics shows that LC3 stabilizes microtubule networks by decreasing microtubule dynamicity and promoting growth over shortening events.


Subject(s)
Microtubule-Associated Proteins/metabolism , Microtubules/metabolism , Animals , Cytoskeleton/metabolism , HeLa Cells , Humans , Mice , Microtubule-Associated Proteins/genetics , Nocodazole/metabolism , Protein Binding , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Tubulin/genetics , Tubulin/metabolism , Tubulin Modulators/metabolism
8.
J Neurosci Res ; 87(5): 1080-9, 2009 Apr.
Article in English | MEDLINE | ID: mdl-18951470

ABSTRACT

Structural microtubule-associated proteins (MAPs) interact with microtubules to regulate the various dynamic stages of microtubules. The purpose of this study was to measure the impact of myc-tagged MAP1a fragments on microtubule dynamic phases in vivo. Cells from an epithelial kidney cell line (LLCPK1) that had been permanently transfected with human green fluorescent protein (GFP)-alpha-tubulin were transiently transfected with myc-tagged MAP1a fragments. Cells expressing MAP1a fragments were used to make direct observations of microtubule dynamics in living cells using fluorescence microscopy. All truncated MAP1a heavy chain fragments that contained the microtubule-binding domain were shown to associate with microtubules. Truncated fragments containing different regions of the projection domain of MAP1a demonstrated variations in their impact on microtubule dynamic events by promoting growth or inhibition of shortening phases. In contrast to MAP1a, MAP2c bundled microtubules and resulted in a complete arrest of microtubule motility. Results from the present study suggest that MAP1a promotes slow, stable growth of microtubules. This type of growth may be important in the maintenance and restructuring of adult neurons.


Subject(s)
Microtubule-Associated Proteins/metabolism , Microtubules/metabolism , Animals , Blotting, Western , Cell Line , Gene Expression , Green Fluorescent Proteins/metabolism , Humans , Mice , Microscopy, Fluorescence , Swine , Transfection , Tubulin/metabolism
9.
J Acquir Immune Defic Syndr ; 43(3): 257-69, 2006 Nov 01.
Article in English | MEDLINE | ID: mdl-16967044

ABSTRACT

We have previously shown decreased expression of the interleukin (IL)-7 receptor alpha-chain (CD127) on CD8 T-cells in HIV-infected patients and an apparent recovery of this receptor in those receiving antiretroviral therapy with sustained viral suppression. Here, we demonstrate that the HIV Tat protein specifically downregulates cell surface expression of CD127 on human CD8 T-cells in a dose- and time-dependent manner. The effects of Tat on CD127 expression could be blocked with anti-Tat monoclonal antibodies or by preincubating Tat with heparin. Tat had no effect on the expression of other cell surface proteins examined, including CD132, or on cell viability over 72 hours. Further, CD127 expression was not altered by other HIV proteins, including gp160 or Nef. Preincubation of purified CD8 T-cells with Tat protein inhibited CD8 T-cell proliferation and perforin synthesis after stimulation with IL-7. Because IL-7 signaling is essential for optimal CD8 T-cell proliferation and function, the downregulation of CD127 and apparent inhibition of cytotoxic activity by Tat may play an important role in HIV-induced immune dysregulation and impaired cell-mediated immunity.


Subject(s)
CD8-Positive T-Lymphocytes/drug effects , Gene Products, tat/pharmacology , HIV/genetics , Leukocytes, Mononuclear/metabolism , Receptors, Interleukin-7/metabolism , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Cells, Cultured , Down-Regulation/drug effects , Gene Expression Regulation, Viral , Interleukin-7/biosynthesis , Leukocytes, Mononuclear/drug effects , Receptors, Interleukin-7/blood , tat Gene Products, Human Immunodeficiency Virus
SELECTION OF CITATIONS
SEARCH DETAIL
...